<DOC>
	<DOCNO>NCT01804114</DOCNO>
	<brief_summary>The primary endpoint study determine subject receive continuous infusion local anesthetic follow laparoscopic ventral hernia repair , pain pump instal described treat post surgical pain low incidence pain patient treat placebo , saline-filled pain pump.The secondary endpoint study determine subject receive continuous infusion local anesthetic follow laparoscopic ventral hernia repair , pain pump instal described treat post surgical pain low utilization narcotic analgesic medication patient treat placebo , saline-filled pain pump .</brief_summary>
	<brief_title>Continuous Local Anesthetic Infusion Following Hernia Repair</brief_title>
	<detailed_description>Patients screen determine study eligibility use inclusion/exclusion criterion . Following consent process , subject randomly assign treatment arm ( anesthetic placebo group ) . Baseline data collect prior surgical implantation pain pump delivery system . Both study control group able receive supplemental medication breakthrough pain determine surgeon . Post-operative data collect three week follow surgery .</detailed_description>
	<mesh_term>Hernia</mesh_term>
	<mesh_term>Hernia , Ventral</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Anesthetics , Local</mesh_term>
	<criteria>&gt; 18 year ASA I , II , III Scheduled Laparoscopic Ventral Hernia Repair ASA IV great Needing emergency surgery Known history drug abuse GI , liver , kidney condition , per surgeon 's opinion , could interfere absorption , distribution , metabolism excretion drug use duration study Patients prior allergic reaction dependency morphine , demerol , dilaudid , fentanyl , marcaine ( bupivicaine ) , lidocaine , ropivicaine .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>